ClinicalTrials.Veeva

Menu

Medical Nutrition Formulations Enriched with Postbiotics for the Management of Gastrointestinal Disorders (ABB S3/ABB C22)

A

AB Biotek

Status and phase

Completed
Early Phase 1

Conditions

Diarrhoea of Diverse Aetiology Requiring Oral Rehydration Therapy
Diarrhoea and Gastrointestinal Symptoms Secondary to Enteral Nutrition

Treatments

Dietary Supplement: ABB S3
Dietary Supplement: Placebo
Dietary Supplement: ABB C22

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT06738420
2022-003423-18

Details and patient eligibility

About

Efficacy and tolerability of ABB i5 prebiotic and ABB C22 postbiotics for the management of constipation and gastrointestinal well-being: a pilot trial

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Inpatients of the centre

    • Diagnostic of diarrhoea: increase in daily faecal weight > 200 g (as per the Centre protocol).
    • Subjects who as per the Centre protocol require Oral rehydration therapy
    • Patients with the ability to take the study product orally

Exclusion criteria

  • History of allergy, idiosyncrasy, hypersensitivity or adverse reactions to the active principle or to any of the excipients.

    • History or evidence of any medical conditions or medication used that, in the opinion of the principal investigator, could affect the safety of the subjects or interfere with the study evaluations
    • Patients in situation of last days
    • Amytriptilin and masalazine treatment (anti-depressives)
    • Laxatives

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 4 patient groups, including a placebo group

ABB S3 - active
Experimental group
Description:
Postbiotic ABB S3 for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition
Treatment:
Dietary Supplement: ABB S3
ABB S3 - Placebo
Placebo Comparator group
Description:
Placebo for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: Placebo
ABB C22 - active
Experimental group
Description:
Oral Rehydration Solution containing postbiotics ABB C22 for the management of diarrhoea signs of dehydration
Treatment:
Dietary Supplement: ABB C22
ABB C22 - placebo
Placebo Comparator group
Description:
Oral Rehydration Solution containing placebo for the management of diarrhoea signs of dehydration
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems